Trust Point Inc. Has $1.32 Million Stake in Moelis & Company (NYSE:MC)

Trust Point Inc. trimmed its position in shares of Moelis & Company (NYSE:MC) by 6.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,801 shares of the asset manager’s stock after selling 1,175 shares during the period. Trust Point Inc.’s holdings in Moelis & Company were worth $1,315,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in MC. Bank of Montreal Can boosted its position in Moelis & Company by 2.7% during the second quarter. Bank of Montreal Can now owns 7,181 shares of the asset manager’s stock worth $409,000 after purchasing an additional 192 shares during the period. The Manufacturers Life Insurance Company boosted its position in shares of Moelis & Company by 12.3% in the second quarter. The Manufacturers Life Insurance Company now owns 54,462 shares of the asset manager’s stock valued at $3,097,000 after acquiring an additional 5,954 shares during the period. Algert Global LLC bought a new stake in shares of Moelis & Company in the second quarter valued at about $382,000. Sanctuary Advisors LLC bought a new stake in shares of Moelis & Company in the second quarter valued at about $554,000. Finally, GAMMA Investing LLC boosted its position in shares of Moelis & Company by 115.8% in the third quarter. GAMMA Investing LLC now owns 995 shares of the asset manager’s stock valued at $68,000 after acquiring an additional 534 shares during the period. 91.53% of the stock is currently owned by institutional investors and hedge funds.

Moelis & Company Trading Down 0.9 %

NYSE MC opened at $77.57 on Tuesday. The firm has a market capitalization of $5.81 billion, a P/E ratio of 146.36 and a beta of 1.40. The business has a fifty day simple moving average of $75.30 and a 200 day simple moving average of $70.51. Moelis & Company has a 12 month low of $46.24 and a 12 month high of $81.60.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Wells Fargo & Company dropped their price target on Moelis & Company from $78.00 to $77.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 14th. Keefe, Bruyette & Woods raised Moelis & Company from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $71.00 to $86.00 in a research note on Friday, December 20th. Morgan Stanley raised Moelis & Company from an “underweight” rating to an “overweight” rating and boosted their price target for the company from $66.00 to $92.00 in a research note on Monday, December 9th. Finally, UBS Group boosted their price target on Moelis & Company from $54.00 to $60.00 and gave the company a “sell” rating in a research note on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $70.67.

About Moelis & Company

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.